Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose D-Serine in Recent Onset Schizophrenia
NCT01459029Phase 2Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Nov 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of d-serine in schizophrenia, sponsored by Hadassah Medical Organization. Status: unknown.
02
Drugs
d-serine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01459029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01459029.